Promising fields in the study of the pathogenesis of necrobiosis lipoidica

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The diagnosis of necrobiosis lipoidica is gaining significance owing to the increase in the incidence of diabetes mellitus. Several theories regarding the etiopathogenesis of necrobiosis lipoidica indicate the distinctive role of transport proteins of the Glut family, as well as the role of matrix metalloproteinase in the development of this dermatosis.

Full Text

Restricted Access

About the authors

N. P. Teplyuk

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: koroleva_v_s1@student.sechenov.ru
ORCID iD: 0000-0002-5800-4800

Department of Dermatology and Venerology of Institute of Clinical Medicine n.a. N.V. Sklifosovsky

Russian Federation, 119991, Moscow

N. L. Shimanovskiy

Pirogov Russian National Research Medical University

Email: koroleva_v_s1@student.sechenov.ru

Department of Molecular Pharmacology and Radiobiology

Russian Federation, Moscow, 117997

V. A. Varshavsky

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: koroleva_v_s1@student.sechenov.ru
ORCID iD: 0000-0002-5855-3092

Department of Pathological Anatomy n.a. Acad. A.I. Strukova Institute of Clinical Medicine n.a. N.V. Sklifosovsky

Russian Federation, 119991, Moscow

V. S. Koroleva

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: koroleva_v_s1@student.sechenov.ru
ORCID iD: 0000-0002-9945-7830

MD, postgraduate of Department of Dermatology and Venerology

Russian Federation, 119991, Moscow

References

  1. Global report on diabetes. Geneva: World Health Organization; 2018. License: CC BY-NC-SA 3.0 IGO
  2. Marchetti F., Gerarduzzi T., Longo F., Faleschini E., Ventura A., Tonini G. Maturity-onset diabetes of the young with necrobiosis lipoidica and granuloma annulare. Pediatric. Dermatol. 2006; 23(3): 247-50.
  3. Lause M., Kamboj A., Fernandez Faith E. Dermatologic manifestations of endocrine disorders. Transl. Pediatr. 2017; 6(4): 300-12. doi: 10.21037/tp.2017.09.08
  4. Kalamkaryan А.А., Mordovtsev V.N., Trofimova L.Ya. Clinical Dermatology. Rare and Atypical Dermatoses. Yerevan: Ayastan; 1989: 339-42. (in Russian)
  5. Teplyuk N.P., Koshelkeva I.V., Plieva L.R., Lepekhova A.A. Total systems oxygen ozone therapy for necrobiosis lipoidica. Russian Journal of Skin and Venereal Diseases (Rossiyskii Zhurnal Kozhnykh i Venericheskikh Boleznei). 2012; 15(2): 35-40. (in Russian)
  6. Semenova D.A., Tokmakova A.Yu. Necrobiosis lipoidica in diabetic patients: pathogenetic and clinical features. Diabetes. Russian Journal (Sakharnyy diabet). 2011; (4): 51-4. (in Russian)
  7. de Pablos Vicente M.A., Leal Hernandez M., Balanza Galindo S., Abellan Aleman J. Evaluation of therapeutic inertia in lipid lowering treatment of primary care patients with high cardiovascular risk. Aten. Primaria. 2012; 44(3): e14–5. doi: 10.1016/j.aprim.2011.02.011
  8. Petrova G.A., Levin G.Ya. Some indicators of hemorheology in patients with necrobiosis lipoidica. Bulletin of Dermatology and Venereology (Vestnik dermatologii i venerologii). 1989; 65(12):45-8. (in Russian)
  9. Abramova E.A., Polyanskaya N.P. Сorrelation necrobiosis lipoidica and diabetes. Bulletin of Dermatology and Venereology (Vestnik dermatologii i venerologii). 1985; 61(2):36-8. (in Russian)
  10. Hammer E., Lilienthal E., Hofer S.E., Schulz S., Bollow E., Holl R.W.; DPV Initiative and the German BMBF Competence Network for Diabetes Mellitus. Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus. Diabet. Med. 2017; 34(1): 86-92.
  11. Krivosheev A.B. Features of the course of dermatoses in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Bulletin of Dermatology and Venereology (Vestnik dermatologii i venerologii). 1988; 63(11): 24-7. (in Russian)
  12. Butov Yu.S., Iliyena T.A., Vavilov A.M. Clinical and histological signs of necrobiosis lipoidica. Russian Journal of Skin and Venereal Diseases (Rossiyskii Zhurnal Kozhnykh i Venericheskikh Boleznei). 2003; 6(4): 38-42. (in Russian)
  13. Mendes A.L., Miot H.A., Haddad V. Junior. Diabetes mellitus and the skin. An Bras. Dermatol. 2017; 92(1):8-20. doi: 10.1590/abd1806-4841.20175514
  14. Shaposhnikov O.K., Hazizov I.E. Current aspects of the pathogenesis and therapy of granuloma annulare and necrobiosis lipoidica. Bulletin of Dermatology and Venereology (Vestnik dermatologii i venerologii). 1985; (5): 4-8. (in Russian)
  15. Krivosheev A.B., Kondratova М.А., Tuguleva Т.А., Morozov D.V. Necrobiosis lipoidica and the metabolic syndrome. Russian Journal of Skin and Venereal Diseases (Rossiyskii Zhurnal Kozhnykh i Venericheskikh Boleznei), 2013; 16(6): 31--6. (in Russian)
  16. Holland C., Givens V., Smoller B.R. Expression of the human erythrocyte glucose transporter Glut-1 in areas of sclerotic collagen in necrobiosis lipoidica. J. Cutan. Pathol. 2001; 28(6):287-90.
  17. Stanirowski P.J., Szukiewicz D., Pyzlak M., Abdalla N., Sawicki W., Cendrowski K. Impact of pre-gestational and gestational diabetes mellitus on the expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 in human term placenta. Endocrine. 2017; 55(3):799-808.
  18. Stanirowski P.J., Szukiewicz D., Pazura-Turowska M., Sawicki W., Cendrowski K. Placental expression of glucose transporter proteins in pregnancies complicated by gestational and pregestational diabetes mellitus. Can. J. Diabetes. 2018; 42(2):209-17.
  19. Miele C., Formisano P., Condorelli G., Caruso M., Oriente F., Andreozzi F., et al. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Diabetologia 1997; 40(4):421-9.
  20. Saarialho-Kere U.K., Chang E.S., Welgus H.G., Parks W.C. Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in granuloma annulare and necrobiosis lipoidica diabeticorum. J. Invest. Dermatol. 1993; 100(3):335-42.
  21. Kochet К.А. Features of epidemiology and clinical manifestations in patients with necrobiosis lipoidica. Dermatology and Venereology (Dermatolohiya ta Venerolohiya). 2017; 4(78): 47-51. (in Ukraine)
  22. Pellicano R., Caldarola G., Filabozzi P., Zalaudek I. Dermoscopy of necrobiosis ipoidica and granuloma annulare. Dermatology. 2013; 226(4):319-23.
  23. Gadzhimuradov М.N., Asadulaeva Z.G. Clinical features of necrobiosis lipoidica. Clinical Dermatology and Venereology. Russian Journal (Klinicheskaya dermatologiya i venerologiya). 2016; 15(4):32-5. (in Russian)
  24. Souza F.H., Ribeiro C.F., Pereira M.A., Mesquita L., Fabrício L. Simultaneous occurrence of ulcerated necrobiosis lipoidica and granuloma annulare in a patient: case report. An Bras. Dermatol. 2011; 86(5):1007-10.
  25. Wee E., Kelly R. Pentoxifylline: An effective therapy for necrobiosis lipoidica. Australas J. Dermatol. 2017; 58(1):65-8. doi: 10.1111/ajd.12420.
  26. Gualdi G., Monari P., Farisoglio C., Calzavara-Pinton P. Juvenile ulcerated necrobiosis lipoidica successfully treated with oral cyclosporin A. G. Ital. Dermatol. Venereol. 2013; 148(6): 703-4.
  27. Shah S.D., Kale G.V. Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with oral thalidomide. Indian Dermatol. Online J. 2016; 7(1):43-5.
  28. Eberle F.C., Ghoreschi K., Hertl M. Fumaric acid esters in severe ulcerative necrobiosis lipoidica: a case report and evaluation of current therapies. Acta Derm. Venereol. 2010; 90(1):104-6.
  29. Kreuter A., Knierim C., Stucker M., Pawlak F., Rotterdam S., Altmeyer P., Gambichler T. Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study. Br. J. Dermatol. 2005; 153(4):802-7.
  30. Kavala M., Sudogan S., Zindanci I., Kocaturk E., Can B., Turkoglu Z., Altintas S. Significant improvement in ulcerative necrobiosis lipoidica with hydroxychloroquine. Int. J. Dermatol. 2010; 49(4):467-9.
  31. Narbutt J., Torzecka J.D., Sysa-Jedrzejowska A., Zalewska A. Long-term results of topical PUVA in necrobiosis lipoidica. Clin. Exp. Dermatol. 2006; 31(1):65-7.
  32. Attili S.K., Dawe R.S., Ibbotson S.H. Ultraviolet A1 phototherapy: One center’s experience. Indian J. Dermatol. Venereol. Leprol. 2017; 83(1):60-5.
  33. Radakovic S., Weber M., Tanew A. Dramatic response of chronic ulcerating necrobiosis lipoidica to ultraviolet A1 phototherapy. Photodermatol. Photoimmunol. Photomed. 2010; 26(6):327-9.
  34. Basoulis D., Fragiadaki K., Tentolouris N., Sfikakis P.P., Kokkinos A. Anti-TNFalpha treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: A case report and review of the literature. Metabolism. 2016; 65(4): 569--73.
  35. Guedes R., Leite I., Baptista A., Rocha N. Ulcerative necrobiosis lipoidica: is there a place for anti-TNFalpha treatment? Case Rep. Med. 2012; 2012: 854738.
  36. Suarez-Amor O., Perez-Bustillo A., Ruiz-Gonzalez I., Rodriguez-Prieto M.A. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature. Dermatology. 2010; 221(2): 117--21.
  37. Peckruhn M., Tittelbach J., Elsner P. Update: Treatment of necrobiosis lipoidica. J. Deutsch. Dermatol. Ges. 2017; 15(2): 151--7. https://doi.org/10.1111/ddg.13186.
  38. Bonura C., Frontino G., Rigamonti A., Battaglino R., Favalli V., Ferro G., et al. Necrobiosis lipoidica diabeticorum: A pediatric case report. Dermatoendocrinol. 2014; 6(1): e27790.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. The clinical picture of a typical papular form of necrobiosis lipoid: there is a papule of rounded outlines with clear boundaries.

Download (1MB)
3. Fig. 2. The clinical picture of a formed plaque with central atrophy in a patient with necrobiosis lipoid.

Download (1MB)
4. Fig. 3. Histological specimen. Lymphohistiocytic infiltrate around the area of collagen necrobiosis.

Download (1MB)
5. Fig. 4. Histological specimen. Extracellular lipid deposition.

Download (1MB)

Copyright (c) 2020 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86501 от 11.12.2023 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г
.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies